We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.
- Authors
Saad, Fred; Gleason, Donald M; Murray, Robin; Tchekmedyian, Simon; Venner, Peter; Lacombe, Louis; Chin, Joseph L; Vinholes, Jeferson J; Goas, J Allen; Chen, Bee; Zoledronic Acid Prostate Cancer Study Group
- Abstract
Bone metastases are a common cause of morbidity in patients with prostate carcinoma. We studied the effect of a new bisphosphonate, zoledronic acid, which blocks bone destruction, on skeletal complications in prostate cancer patients with bone metastases.
- Publication
Journal of the National Cancer Institute, 2002, Vol 94, Issue 19, p1458
- ISSN
0027-8874
- Publication type
Journal Article
- DOI
10.1093/jnci/94.19.1458